Planning Placement and Measuring Process: The ASAM Criteria and the Washington Circle Performance Measures
Moderator: David R. Gastfriend, M.D.
Deborah Garnick, Sc.D. & Constance Horgan, Sc.D.

Treatment Outcome and Quality Improvement
James R. McKay, Ph.D., Selecting Continuing Care Models on the Basis of Initial Progress in Treatment
Patricia A. Ebener , Partnering to improve quality of care in addiction treatment
Grant R. Grissom, Ph.D., Evidence-based Treatment and Quality Improvement: Results from Integration of a NIDA-Sponsored ASI-based Automated Outcomes System into Routine CD Treatment
David S. Festinger, Ph.D., Matching Judicial Supervision to Client Risk Status in Drug Courts

Housing, Employment, Welfare Issues in Treatment
Stefan G. Kertesz, MD MSc, Is addiction treatment enough? Long-term employment and housing outcomes among treated homeless cocaine abusers
Kim Blanchard, Ph.D., Twenty-Four Month Outcomes of a Public Health Approach for Assisting Substance Abusing TANF Women in New Jersey
Kirk M. Broome, Ph.D., Current Practices in Systems Integration among Outpatient Drug-Free Treatment Providers

Co-Occurring Substance Use & Mental Health Issues in Treatment
Mark Edlund, Ph.D., Substance abuse treatment and mental health care use by adults with
co-occurring disorders
Mark P. McGovern, Ph.D., Development and application of an index of dual diagnosis capability in addiction treatment programs
Stacy A Sterling MSW, MPH, Chemical dependency and psychiatric services for adolescents in private managed care: Implications for outcomes
Laurel Mangrum, Ph.D. & Richard Spence, Ph.D., A Comparison of Characteristics and Outcomes of clients with Co-occurring Psychological and Substance Abuse Treatment Population

Health Services Research in NIDA’s Clinical Trials Network
Dennis McCarty, Ph.D., Counselors Working in Treatment Units Participating in The National Drug Abuse Treatment Clinical Trials Network
Robert F. Forman, Ph.D., Patient Feedback: A Performance Feedback System for Improving Engagement in Outpatient Addiction Treatment
Joseph Guydish, Ph.D., Adoption of Innovative Practices in the Context of Clinical Trials
Kathryn Magruder, Ph.D., M.P.H., Program influences on recruitment and retention of minority participants in addictions treatment research
Beverly Pringle, Ph.D., Future Directions and Funding Opportunities at the National Institute on Drug Abuse

Organizational Issues in Substance Abuse Treatment
Laurie Russell MS, RN & Kenneth Stoller M.D., Operationalizing integrated managed care for a Medicaid population with substance abuse and high medical expenses
Lori Ducharme, Ph.D., Comprehensive treatment services: Comparing the public and private sectors
Constance M. Horgan, Sc.D., Getting Into and Staying in Treatment: Changes in How Health Plans Provide Addiction Services
Bret Fuller, Ph.D., Elimination of Methadone Benefits in the Oregon Health Plan; Patient Impacts

Financing and Cost of Substance Abuse Treatment
Gary A. Zarkin & Laura J. Dunlap, Benefits and Costs of Methadone Treatment: Results from a Lifetime Simulation Model
Dennis Deck, Ph.D., Impact of Financing on Retention in Publicly Funded Methadone Treatment
Kathryn McCollister, Ph.D., Re-estimating the Cost of Crime to Society
Carmen L. Masson, Ph.D., Impact of drug treatment linkage interventions on health service use and costs: 6-month outcomes from a randomized controlled trial

Financing and Costs II
Elizabeth Agius, Impact of turnover on organizational climate of substance abuse treatment clinics
Victoria L. Brown, Ph.D., Employment: Tertiary Drug Use Prevention for Welfare Recipients?
Alex J. Cowell, Examining Variation in Treatment Costs: A Cost Function for Outpatient Methadone Treatment Programs

Keynote Address
Nora D. Volkow, M.D.